Every open market buy and sale of Emergent BioSolutions Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $986K sold.
Buying and selling by month
open market, last 12 monthsGet an alert when EBS insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an EBS officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every EBS insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | Donald W DeGolyerDirector | Sale plan | 17,800 | $7.09 | $126K | 111,921 | Oct 7Form 4 |
| Oct 1, 2026 | Paul Anthony WilliamsSVP, Products Business | Sale plan | 3,000 | $6.53 | $20K | 156,098 | Oct 5Form 4 |
| Jul 1, 2026 | Paul Anthony WilliamsSVP, Products Business | Sale plan | 3,000 | $8.40 | $25K | 159,098 | Jul 2Form 4 |
| May 1, 2026 | Sujata Tyagi DayalDirector | Sale plan | 13,761 | $8.40 | $116K | 100,563 | May 4Form 4 |
| May 1, 2026 | Donald W DeGolyerDirector | Sale plan | 15,481 | $8.40 | $130K | 129,721 | May 4Form 4 |
| May 1, 2026 | Kathryn C ZoonDirector | Sale plan | 17,202 | $8.40 | $144K | 79,941 | May 4Form 4 |
| Apr 30, 2026 | Keith KatkinDirector | Sale plan | 15,481 | $8.28 | $128K | 96,294 | May 4Form 4 |
| Apr 1, 2026 | Paul Anthony WilliamsSVP, Products Business | Sale plan | 4,000 | $8.44 | $34K | 62,681 | Apr 3Form 4 |
| Dec 5, 2025 | Ronald RichardDirector | Sale | 21,984 | $11.97 | $263K | 98,417 | Dec 9Form 4 |
| Nov 10, 2025 | Donald W DeGolyerDirector | Sale | 17,801 | $10.54 | $188K | 119,858 | Nov 12Form 4 |
| Nov 7, 2025 | Sujata Tyagi DayalDirector | Sale | 8,552 | $10.00 | $86K | 88,980 | Nov 10Form 4 |
| Oct 7, 2025 | Coleen GlessnerEVP, Quality & Ethics, and CPL | Sale | 30,608 | $10.00 | $306K | 144,319 | Oct 16Form 4 |
| Aug 15, 2025 | Kathryn C ZoonDirector | Sale plan | 7,086 | $8.87 | $63K | 71,799 | Aug 18Form 4 |
| Aug 12, 2025 | Donald W DeGolyerDirector | Sale | 7,844 | $8.65 | $68K | 137,659 | Aug 13Form 4 |
| May 23, 2025 | Keith KatkinDirector | Sale plan | 7,844 | $6.30 | $49K | 86,431 | May 28Form 4 |
EBS insider trading FAQ
Are EBS insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of EBS on the open market in 0 trades, and 6 sold $986K in 9 trades, 73% of that under pre-arranged trading plans.
When did an EBS insider last buy shares?
Joseph C Papa (President and CEO) bought 60,000 shares for $350K on May 13, 2025, reported on May 15, 2025.
When did an EBS insider last sell shares?
Donald W DeGolyer (Director) sold 17,800 shares for $126K on Oct 7, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
